Cybersecurity in healthcare products will no longer be an afterthought in the US. From October 1, 2023, every new medical device with known vulnerabilities or that lacks a secure design will be rejected by the US Food and Drug Administration (FDA) and not allowed to be sold on the US market.

Source: Infosecurity